查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813982

被忽視的熱帶疾病治療市場規模、佔有率和趨勢分析報告：按疾病、產品、地區和細分市場預測，2025-2033 年

Neglected Tropical Disease Treatment Market Size, Share & Trends Analysis Report By Disease (Dengue, Rabies, Trachoma, Chagas Disease), By Product (Drugs, Vaccines), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

被忽視的熱帶疾病治療市場摘要

預計 2024 年全球被忽視的熱帶疾病治療市場價值為 39.6 億美元，到 2033 年將達到 60.4 億美元，2025 年至 2033 年的複合年成長率為 4.78%。

這些治療的需求是由低收入地區被忽視的熱帶疾病的日益流行，以及藥物開發的進步和旨在根除這些疾病的全球衛生計劃所推動的。

被忽視的熱帶疾病治療市場受到各種全球衛生計劃、藥物研發進展和創新給藥方式的顯著影響。推動該市場成長的關鍵因素是各國政府和國際衛生組織日益成長的關注。世界衛生組織 (WHO) 有效協調了針對淋巴絲蟲病、沙眼和土源性蠕蟲等疾病的大規模藥物管理 (MDA) 計畫。據 WHO 稱，2025 年 4 月，美國撤回了對被忽視熱帶疾病 (NTD) 計畫的資助，19 年間影響了 47 項宣傳活動。這次撤資影響了 1.43 億人，並擾亂了大規模治療活動。經費削減也阻礙了研究，並威脅到根除淋巴絲蟲病、盤尾絲蟲病和血吸蟲病等疾病的進展。這些努力，加上全球對抗愛滋病、結核病和瘧疾基金等組織的承諾，對於減輕疾病負擔至關重要，尤其是在撒哈拉以南非洲和東南亞等資源匱乏的地區。

被忽視的熱帶疾病治療市場的另一個關鍵驅動力是專注於改進藥物配方，以應對被忽視的疾病帶來的獨特挑戰。正在開發新的治療方法以提高療效、縮短治療時間並提高患者的依從性。根據通訊報道，諾華公司於 2025 年 5 月承諾，儘管資金可能削減，但仍將繼續生產瘧疾和麻風病治療藥物。該公司每年生產 2,800 萬個療程的瘧疾治療藥物，其中大部分以非營利價格出售。儘管面臨國際援助減少的挑戰，諾華仍投資約 4.9 億美元用於瘧疾和被忽視的熱帶疾病研究，並致力於提供基本藥物。儘管全球衛生資金面臨潛在挑戰，例如官方發展援助削減，但這些公司繼續在確保最需要的人獲得治療方面發揮關鍵作用。

在技​​術進步方面，新型藥物輸送系統與數位健康創新的結合正在提高治療的有效性和可及性。例如，奈米技術正在被研究作為提高藥物生物生物有效性的一種方法，從而能夠在資源有限的環境中實現更有效的治療。 2025年7月，瑞士衛​​生當局批准了Coatem Baby（也稱為Riamet Baby），這是第一種專為新生兒和體重少於11磅的嬰兒設計的瘧疾治療藥物。這種治療方法由瘧疾藥物研發基金與諾華公司合作開發，旨在填補一個關鍵的治療空白。它將在幾個非洲國家推廣，在這些國家，瘧疾仍然是五歲以下兒童死亡的主要原因。這些技術核准不僅改善了治療效果，還使以前缺乏可靠醫療選擇的人更容易獲得治療。此外，行動醫療技術正在幫助縮小醫療服務可近性的差距，使偏遠地區能夠更好地監測和管理疾病，進一步增加市場潛力。

這些進展反映出，在政府、製藥公司和國際衛生組織合作的推動下，NTD治療領域正蓬勃發展。隨著新藥配方的出現、大型製藥企業的承諾以及技術創新，市場有望繼續發展，最終實現控制並根除被忽視的熱帶疾病的目標。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 被忽視的熱帶疾病治療市場變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析-波特五力分析
    • PESTLE分析
    • 管道分析
    • 專利到期分析
    • 定價分析

第4章被忽視的熱帶疾病治療市場：疾病業務分析

  • 2024 年及 2033 年疾病市佔率
  • 疾病細分儀表板
  • 2021-2033 年市場規模與預測、疾病特定趨勢分析
  • 登革熱
  • 狂犬病
  • 沙眼
  • 布魯裡潰瘍
  • 約斯
  • 麻風
  • 南美錐蟲病
  • 非洲人類錐蟲病（昏睡病）
  • 利什曼原蟲症
  • 土源性蠕蟲病
  • 其他

第5章被忽視的熱帶疾病治療市場：產品業務分析

  • 2024年及2033年產品市場佔有率
  • 產品細分儀表板
  • 市場規模、預測與趨勢分析（按產品，2021-2033 年）
  • 製藥
  • 疫苗

第6章被忽視的熱帶疾病治療市場：區域估計和趨勢分析

  • 2024 年及 2033 年區域市佔率分析
  • 區域市場儀表板
  • 2021-2033 年市場規模與預測趨勢分析：
  • 北美洲
    • 按國家/地區，2021-2033 年
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 參與者概覽
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • F. Hoffmann-La Roche Ltd
    • Bayer AG
    • GlaxoSmithKline plc
    • Novartis AG
    • Pfizer, Inc.
    • Eisai Co. Ltd.
    • Sanofi
    • Astellas Pharma
    • Takeda Pharmaceutical Company Limited
    • Gilead Sciences.
Product Code: GVR-3-68038-787-2

Neglected Tropical Disease Treatment Market Summary

The global neglected tropical disease treatment market size was estimated at USD 3.96 billion in 2024 and is projected to reach USD 6.04 billion by 2033, growing at a CAGR of 4.78% from 2025 to 2033. The demand for these treatments is driven by the increasing prevalence of neglected tropical diseases in low-income regions, as well as advancements in drug development and global health initiatives aimed at eradicating these diseases.

Various global health initiatives, advancements in drug development, and innovative delivery methods greatly influence the neglected tropical disease treatment market. A major factor driving growth in this market is increasing attention from governments and international health organizations. The World Health Organization (WHO) has effectively coordinated mass drug administration (MDA) programs for diseases like lymphatic filariasis, trachoma, and soil-transmitted helminths. According to the World Health Organization (WHO), in April 2025, the United States withdrew funding from NTD programs, impacting 47 campaigns over 19 years. This withdrawal affected 143 million people and disrupted mass treatment efforts. The funding reductions also impeded research, threatening progress toward eliminating diseases such as lymphatic filariasis, onchocerciasis, and schistosomiasis. These efforts, along with commitments from organizations like the Global Fund to Fight AIDS, Tuberculosis, and Malaria, are essential in reducing the disease burden in resource-limited settings, especially in sub-Saharan Africa and Southeast Asia.

Another significant driver of the NTD treatment market is the focus on advancing drug formulations to address the unique challenges posed by neglected diseases. New treatments are being developed to improve efficacy, reduce treatment duration, and enhance patient compliance. According to Reuters, in May 2025, Novartis committed to continuing the production of malaria and leprosy medicines despite potential funding cuts. The company produces 28 million malaria treatment courses annually, mostly sold at not-for-profit prices. Despite challenges from reduced international aid, Novartis remains dedicated to supplying essential medicines, investing nearly USD 490 million in research for malaria and neglected tropical diseases. Despite potential challenges in global health funding, such as cuts in official development assistance, these companies continue to play a vital role in ensuring that treatments remain available to those who need them the most.

In terms of technological advancements, the integration of novel drug delivery systems and digital health innovations is improving both the effectiveness and accessibility of treatments. Nanotechnology, for example, is being explored as a way to enhance the bioavailability of drugs, allowing for more effective treatments even in resource-constrained environments. In July 2025, Swiss medical authorities approved Coartem Baby (also known as Riamet Baby), the first malaria treatment specifically designed for newborns and infants weighing under 11 pounds. Developed by Medicines for Malaria Venture in collaboration with Novartis, the drug addresses a critical treatment gap. It is expected to be rolled out in several African nations, where malaria remains a leading cause of death among children under five. These innovations are not only improving therapeutic outcomes but also making treatments more accessible to populations that previously lacked reliable healthcare options. Additionally, mobile health technologies are helping to bridge the gap in healthcare access, enabling better disease monitoring and management in remote areas, further enhancing the market's potential.

These developments reflect a growing momentum in the NTD treatment space, driven by collaborative efforts between governments, pharmaceutical companies, and global health organizations. With new drug formulations, the commitment of major pharmaceutical players, and technological innovations, the market is poised to continue evolving in its mission to control and ultimately eradicate neglected tropical diseases.

Global Neglected Tropical Disease Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global neglected tropical disease treatment market report based on disease, product, and region:

  • Disease Outlook (Revenue, USD Million, 2021 - 2033)
  • Dengue
  • Rabies
  • Trachoma
  • Buruli Ulcer
  • Yaws
  • Leprosy
  • Chagas Disease
  • Human African Trypanosomiasis (Sleeping Sickness)
  • Leishmaniases
  • Soil-transmitted Helminthiases
  • Others
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Drugs
    • Anti-Parasite
    • Antifungal
    • Antibiotics
    • Others
  • Vaccines
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Disease
    • 1.2.2. Product
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Neglected Tropical Disease Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Neglected Tropical Disease Treatment Market: Disease Business Analysis

  • 4.1. Disease Market Share, 2024 & 2033
  • 4.2. Disease Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Disease, 2021 to 2033 (USD Million)
  • 4.4. Dengue
    • 4.4.1. Dengue Market, 2021 - 2033 (USD Million)
  • 4.5. Rabies
    • 4.5.1. Rabies Market, 2021 - 2033 (USD Million)
  • 4.6. Trachoma
    • 4.6.1. Trachoma Market, 2021 - 2033 (USD Million)
  • 4.7. Buruli Ulcer
    • 4.7.1. Buruli Ulcer Market, 2021 - 2033 (USD Million)
  • 4.8. Yaws
    • 4.8.1. Yaws Market, 2021 - 2033 (USD Million)
  • 4.9. Leprosy
    • 4.9.1. Leprosy Market, 2021 - 2033 (USD Million)
  • 4.10. Chagas Disease
    • 4.10.1. Chagas Disease Market, 2021 - 2033 (USD Million)
  • 4.11. Human African Trypanosomiasis (Sleeping Sickness)
    • 4.11.1. Human African Trypanosomiasis (Sleeping Sickness) Market, 2021 - 2033 (USD Million)
  • 4.12. Leishmaniases
    • 4.12.1. Leishmaniases Market, 2021 - 2033 (USD Million)
  • 4.13. Soil-transmitted Helminthiases
    • 4.13.1. Soil-transmitted Helminthiases Market, 2021 - 2033 (USD Million)
  • 4.14. Others
    • 4.14.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Neglected Tropical Disease Treatment Market: Product Business Analysis

  • 5.1. Product Market Share, 2024 & 2033
  • 5.2. Product Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 5.4. Drugs
    • 5.4.1. Drugs Market, 2021 - 2033 (USD Million)
    • 5.4.2. Anti-Parasite
      • 5.4.2.1. Anti-Parasite Market, 2021 - 2033 (USD Million)
    • 5.4.3. Antifungal
      • 5.4.3.1. Antifungal Market, 2021 - 2033 (USD Million)
    • 5.4.4. Antibiotics
      • 5.4.4.1. Antibiotics Market, 2021 - 2033 (USD Million)
    • 5.4.5. Others
      • 5.4.5.1. Others Market, 2021 - 2033 (USD Million)
  • 5.5. Vaccines
    • 5.5.1. Vaccines Market, 2021 - 2033 (USD Million)

Chapter 6. Neglected Tropical Disease Treatment Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America Neglected Tropical Disease Treatment Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Framework
      • 6.4.2.5. U.S. Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Framework
      • 6.4.3.5. U.S. Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Reimbursement Framework
      • 6.4.4.5. Mexico Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Framework
      • 6.5.2.5. Uk Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Framework
      • 6.5.3.5. Germany Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement Framework
      • 6.5.4.5. France Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Target Disease Prevalence
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Reimbursement Framework
      • 6.5.5.5. Italy Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Target Disease Prevalence
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Framework
      • 6.5.6.5. Spain Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Target Disease Prevalence
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Framework
      • 6.5.7.5. Denmark Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Target Disease Prevalence
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Framework
      • 6.5.8.5. Sweden Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Target Disease Prevalence
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement Framework
      • 6.5.9.5. Norway Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Framework
      • 6.6.2.5. Japan Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Framework
      • 6.6.3.5. China Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Framework
      • 6.6.4.5. India Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Framework
      • 6.6.5.5. Australia Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Target Disease Prevalence
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Framework
      • 6.6.6.5. South Korea Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Target Disease Prevalence
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Framework
      • 6.6.7.5. Thailand Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Target Disease Prevalence
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Framework
      • 6.7.2.5. Japan Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Target Disease Prevalence
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Framework
      • 6.7.3.5. China Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Target Disease Prevalence
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Framework
      • 6.8.2.5. South Africa Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Target Disease Prevalence
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Framework
      • 6.8.3.5. Saudi Arabia Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Target Disease Prevalence
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement Framework
      • 6.8.4.5. UAE Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Target Disease Prevalence
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement Framework
      • 6.8.5.5. Kuwait Neglected Tropical Disease Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. F. Hoffmann-La Roche Ltd
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Disease Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Bayer AG
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Disease Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. GlaxoSmithKline plc
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Disease Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Novartis AG
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Disease Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Pfizer, Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Disease Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Eisai Co. Ltd.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Disease Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Sanofi
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Disease Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Astellas Pharma
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Disease Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Takeda Pharmaceutical Company Limited
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Disease Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Gilead Sciences.
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Disease Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global neglected tropical disease treatment market, by region, 2021 - 2033 (USD Million)
  • Table 4. Global neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 5. Global neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 6. North America neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
  • Table 7. North America neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 8. North America neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 9. U.S. neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 10. U.S. neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 11. Canada neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 12. Canada neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 13. Mexico neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 14. Mexico neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 15. Europe neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
  • Table 16. Europe neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 17. Europe neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 18. UK neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 19. UK neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 20. Germany neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 21. Germany neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 22. France neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 23. France neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 24. Italy neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 25. Italy neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 26. Spain neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 27. Spain neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 28. Norway neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 29. Norway neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 30. Denmark neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 31. Denmark neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 32. Sweden neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 33. Sweden neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 34. Asia Pacific neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
  • Table 35. Asia Pacific neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 36. Asia Pacific neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 37. Japan neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 38. Japan neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 39. China neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 40. China neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 41. India neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 42. India neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 43. Australia neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 44. Australia neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 45. South Korea neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 46. South Korea neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 47. Thailand neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 48. Thailand neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 49. Latin America neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
  • Table 50. Latin America neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 51. Latin America neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 52. Brazil neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 53. Brazil neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 54. Argentina neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 55. Argentina neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 56. Middle East & Africa Neglected tropical disease treatment market, by country, 2021 - 2033 (USD Million)
  • Table 57. Middle East & Africa neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 58. Middle East & Africa neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 59. South Africa neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 60. South Africa neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 61. Saudi Arabia neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 62. Saudi Arabia neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 63. UAE neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 64. UAE neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)
  • Table 65. Kuwait neglected tropical disease treatment market, by disease, 2021 - 2033 (USD Million)
  • Table 66. Kuwait neglected tropical disease treatment market, by product, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Neglected tropical disease treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and disease outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Neglected tropical disease treatment market dynamics
  • Fig. 12 Neglected tropical disease treatment market: Porter's five forces analysis
  • Fig. 13 Neglected tropical disease treatment market: PESTLE analysis
  • Fig. 14 Dengue market, 2021 - 2033 (USD Million)
  • Fig. 15 Rabies market, 2021 - 2033 (USD Million)
  • Fig. 16 Trachoma market, 2021 - 2033 (USD Million)
  • Fig. 17 Buruli ulcer market, 2021 - 2033 (USD Million)
  • Fig. 18 Yaws market, 2021 - 2033 (USD Million)
  • Fig. 19 Leprosy market, 2021 - 2033 (USD Million)
  • Fig. 20 Human african trypanosomiasis (sleeping sickness) market, 2021 - 2033 (USD Million)
  • Fig. 21 Leishmaniases market, 2021 - 2033 (USD Million)
  • Fig. 22 Soil-transmitted helminthiases market, 2021 - 2033 (USD Million)
  • Fig. 23 Others market, 2021 - 2033 (USD Million)
  • Fig. 24 Product market, 2021 - 2033 (USD Million)
  • Fig. 25 Drugs market, 2021 - 2033 (USD Million)
  • Fig. 26 Anti-Parasite market, 2021 - 2033 (USD Million)
  • Fig. 27 Antifungal market, 2021 - 2033 (USD Million)
  • Fig. 28 Antibiotics market, 2021 - 2033 (USD Million)
  • Fig. 29 Others market, 2021 - 2033 (USD Million)
  • Fig. 30 Vaccines market, 2021 - 2033 (USD Million)
  • Fig. 31 Neglected tropical disease treatment market revenue, by region
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 North America neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. country dynamics
  • Fig. 35 U.S. neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 36 Canada country dynamics
  • Fig. 37 Canada neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 38 Mexico country dynamics
  • Fig. 39 Mexico neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 40 Europe neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 41 UK country dynamics
  • Fig. 42 UK neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 43 Germany country dynamics
  • Fig. 44 Germany neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 45 France country dynamics
  • Fig. 46 France neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 47 Italy country dynamics
  • Fig. 48 Italy neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 49 Spain country dynamics
  • Fig. 50 Spain neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 51 Norway country dynamics
  • Fig. 52 Norway neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 53 Sweden country dynamics
  • Fig. 54 Sweden neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 55 Denmark country dynamics
  • Fig. 56 Denmark neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 57 Asia Pacific neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 58 Japan country dynamics
  • Fig. 59 Japan neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 60 China country dynamics
  • Fig. 61 China neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 62 India country dynamics
  • Fig. 63 India neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 64 Australia country dynamics
  • Fig. 65 Australia neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 66 South Korea country dynamics
  • Fig. 67 South Korea neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 68 Thailand country dynamics
  • Fig. 69 Thailand neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 70 Latin America neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 71 Brazil country dynamics
  • Fig. 72 Brazil neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 73 Argentina country dynamics
  • Fig. 74 Argentina neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 75 MEA neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 76 South Africa country dynamics
  • Fig. 77 South Africa neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 78 Saudi Arabia country dynamics
  • Fig. 79 Saudi Arabia neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 80 UAE country dynamics
  • Fig. 81 UAE neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 82 Kuwait country dynamics
  • Fig. 83 Kuwait neglected tropical disease treatment market, 2021 - 2033 (USD Million)
  • Fig. 84 Company categorization
  • Fig. 85 Company market position analysis
  • Fig. 86 Strategic framework